Like most forms of cancer, brain cancers are frequently treated with chemotherapy and radiation therapy. Although these treatments can be effective, many times they are not. Scientists around the world study different types of brain cancers to develop new treatment methods.Read More
Science Market Update
In the state of California, more than 176,000 residents arediagnosed with cancer each year and more than $14 billion is spent to fight this disease in California alone. The University of California system has five of the top cancer centers in the country within theseacademic institutions. In September these five UC cancer centers announced that they were teaming up to form a cancer consortium to provide researchers and physicians in California more opportunities to further their work on cancer-related topics. (Image courtesy of Wikimedia Commons)Read More
Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods.
Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)Read More
For cancer patients with tumors, there always a risk of the tumor spreading to a different organ, which makes fighting the cancer more difficult and risky. However, this spread of cancer very rarely occurs on skeletal muscles, which make up nearly 50% of body mass. Why don't these metastatic cancer cells move to and grow on these skeletal muscles? Researchers are still unclear. Now, with the help of a recent $1 million grant from the W.M. Keck Foundation, a research team at Fred Hutchinson Cancer Research Center will focus on studying this elusive topic. (Image courtesy of CC BY-SA 3.0 via Wikimedia Commons)Read More
Join Biotechnology Calendar, Inc. at the January Texas Medical Center BioResearch Product Faire Event and exhibit at the largest medical complex in the world.
With life science expenditures and NIH funding totaling more than 2.2 billion dollars , the BioResearch Product Faire™ offers an excellent opportunity to meet with well-funded researchers. This is further supported by consistent attendance at these trade shows well in excess of 400 researcher attendees, occasionally breaking 500 researchers in attendance.
Texas Medical Center has a new state of the art medical campus under construction which is estimated for completion in 2019 while the Zayed Building at MD Anderson just opend been opened in 2016. We invite you to join us early next year for Houston’s 18th Annual BioResearch Product Faire™.Read More
Last year, the University of Alabama at Birmingham Comprehensive Cancer Center was awarded a five-year, $29 million grant for the National Cancer Institute. The Cancer Center now receives nearly $6M a year in NCI core funding and will continue to do so through 2021. In addition to this core grant, UAB CCC has received over $8.5M in research funding from the NCI during the first half of 2017. This brings their total NCI funding to $14.5 million.Read More
Tags: University of Alabama, University of Alabama Birmingham, Comprehensive Cancer Center, Bioresearch Grant, Bioresearch funding, UAB, UAlab, Alabama, University of Alabama at Birmingham, Cancer, Cancer Center, fight cancer, cancer research, Cancer Treatment, cancer researchers, cancer reserach
Researchers at Texas Medical Center’s (TCM) Houston Methodist Hospital have invented a way to overcome chemotherapy drug resistance and destroy the deadliest type of brain tumors without destroying the surrounding tissue. This targeted approach combines a “smart drug” with chemotherapy. In animal models of human brain cancer, this smart drug prolonged life by over six fold.Read More
Fred Hutchinson Cancer Research Center raised over $13 million in donations at its recent Hutch Holiday Gala, the center's largest annual fundraiser held in Seattle each year. Money from the event will be used to recruit world-class researchers in pediatric oncology and to expand research infrastructure geared specifically toward pediatric cancer research.Read More
The University of Minnesota has been awarded a five-year $8.2 million grant from the The National Cancer Institute (NCI) to develop a cell migration simulator that will predict how cancer cells move throughout the body.Read More
The $10 million gift from Andrew M. and Jane M. Bursky will advance cutting-edge research at the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. Research at the center focuses on harnessing the immune system to fight cancer, infectious diseases, and autoimmune disorders.Read More
Tags: Washington University in St. Louis, Washington University, Washington Univsersity St. Louis, Missouri, MO, Midwest Region, new research funding, cancer research, cancer therapy, Immune System, immune system research, infectious diseases